Improved prefrontal activity in AD/HD children treated with atomoxetine: A NIRS study

Brain and Development

Volumn 37, Issue 1, 2015, Pages 76-87

  Araki, Akiko ^a   Ikegami, Masanaga ^a   Okayama, Akie ^a   Matsumoto, Naoya ^a   Takahashi, Satoru ^a   Azuma, Hiroshi ^a   Takahashi, Masaharu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Atomoxetine; Attention deficit hyperactivity disorder; Continuous performance task; Near infrared spectroscopy; Prefrontal cortex

Indexed keywords

ATOMOXETINE; OXYHEMOGLOBIN; ADRENERGIC RECEPTOR AFFECTING AGENT; PROPYLAMINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN CORTEX; BRAIN FUNCTION; CHILD; CLINICAL ARTICLE; CONTINUOUS PERFORMANCE TEST; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; LONG TERM CARE; MAINTENANCE DRUG DOSE; MALE; NEAR INFRARED SPECTROSCOPY; PREFRONTAL CORTEX; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT DURATION; VENTROLATERAL PREFRONTAL CORTEX; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CLINICAL TRIAL; DRUG EFFECTS; VASCULARIZATION;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; FEMALE; HEMODYNAMICS; HUMANS; MALE; PREFRONTAL CORTEX; PROPYLAMINES; SPECTROSCOPY, NEAR-INFRARED;

EID: 84919462502     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2014.03.011     Document Type: Article

References (58)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders, 4th ed. Text revision (DSM-IV-TR) 2000, American Psychiatric Association, Washington, DC.
2. Arnsten A.F. Stimulants: therapeutic actions in AD/HD. Neuropsychopharmacology 2006, 31:2376-2383.
3. Berridge C.W., Devilbiss D.M. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder. Biol Psychiatry 2011, 69:e101-e111.
4. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002, 27:699-711.
5. Koda K., Ago Y., Cong Y., Kita Y., Takuma K., Matsuda T. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 2010, 114:259-270.
6. Vaidya C.J., Austin G., Kirkorian G., Ridlehuber H.W., Desmond J.E., Glover G.H., et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 1998, 95:14494-14499.
7. Rubia K., Halari R., Cubillo A., Mohammad A.M., Brammer M., Taylor E. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with AD/HD during a rewarded continuous performance task. Neuropharmacology 2009, 57:640-652.
8. Newcorn J.H., Kratochvil C.J., Allen A.J., Casat C.D., Ruff D.D., Moore R.J., et al. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 2008, 165:721-730.
9. Wilens T.E. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2008, 28:S46-53.
10. Fredriksen M., Halmøy A., Faraone S.V., Haavik J. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult AD/HD: a review of controlled and naturalistic studies. Eur Neuropsychopharmacol 2013, 23:508-527.
11. Bolden-Watson C., Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 1993, 52:1023-1029.
12. 3H] nisoxetine binding in rat brain. J Neurochem 1995, 64:2792-2800.
13. Michelson D., Allen A.J., Busner J., Casat C., Dunn D., Kratochvil C., et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 2002, 159:1896-1901.
14. Schulz K.P., Fan J., Bédard A.C., Clerkin S.M., Ivanov I., Tang C.Y., et al. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2012, 69:952-961.
15. Lewis D.A., Melchitzky D.S., Sesack S.R., Whitehead R.E., Auh S., Sampson A. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol 2001, 432:119-136.
16. 2. Psychopharmacology 2006, 188:119-127.
17. Chamberlain S.R., Hampshire A., Müller U., Rubia K., Del Campo N., Craig K., et al. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry 2009, 65:550-555.
18. Bush G., Holmes J., Shin L.M., Surman C., Makris N., Mick E., et al. Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot study. Psychiatry Res 2013, 211:88-91.
19. Arnsten A.F. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 2009, 23(Suppl. 1):33-41.
20. Aron A.R., Poldrack R.A. The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1285-1292.
21. Hart H., Radua J., Nakao T., Mataix-Cols D., Rubia K. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 2013, 70:185-198.
22. Inoue Y., Sakihara K., Gunji A., Ozawa H., Kimiya S., Shinoda H., et al. Reduced prefrontal hemodynamic response in children with AD/HD during the Go/NoGo task: a NIRS study. Neuroreport 2012, 23:55-60.
23. Monden Y., Dan H., Nagashima M., Dan I., Kyutoku Y., Okamoto M., et al. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in AD/HD children using fNIRS. Clin Neurophysiol 2012, 123:1147-1157.
24. Negoro H., Sawada M., Iida J., Ota T., Tanaka S., Kishimoto T. Prefrontal dysfunction in attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy. Child Psychiatry Hum Dev 2010, 41:193-203.
25. Weber P., Lutschg J., Fahnenstich H. Cerebral hemodynamic changes in response to an executive function task in children with attention-deficit hyperactivity disorder measured by near-infrared spectroscopy. J Dev Behav Pediatr 2005, 26:105-111.
26. Weber P., Lutschg J., Fahnenstich H. Methylphenidate-induced changes in cerebral hemodynamics measured by functional near-infrared spectroscopy. J Child Neurol 2007, 22:812-817.
27. Riccio C.A., Waldrop J.J., Reynolds C.R., Lowe P. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 2001, 13:326-335.
28. Montoya A., Hervas A., Cardo E., Artigas J., Mardomingo M.J., Alda J.A., et al. Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naive children and adolescents with attention deficit/hyperactivity disorder. Curr Med Res Opin 2009, 25:2745-2754.
29. Svanborg P., Thernlund G., Gustafsson P.A., Hagglof B., Poole L., Kadesjo B. Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naive Swedish children and adolescents. Eur Child Adolesc Psychiatry 2009, 18:240-249.
30. Dickson R.A., Maki E., Gibbins C., Gutkin S.W., Turgay A., Weiss M.D. Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies. Child Adolesc Psychiatry Ment Health 2011, 5:14. 10.1186/1753-2000-5-14.
31. Yamazaki K. AD/HD-RS-IV Japanese versions. Japanese guideline for the diagnosis and treatment of attention deficit hyperactivity disorder (in Japanese) 2003, 48-54. Jiho, Tokyo. Y. Kanbayashi, K. Saito, M. Kita (Eds.).
32. Michael R.L., Klorman R., Salzman L.F., Borgstedt A.D., Dainer K.B. Normalizing effects of methylphenidate on hyperactive children's vigilance performance and evoked potentials. Psychophysiology 1981, 18:665-677.
33. Losier B.J., McGrath P.J., Klein R.M. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without AD/HD: a meta-analytic review. J Child Psychol Psychiatry 1996, 37:971-987.
34. Halperin J.M., Wolf L., Greenblatt E.R., Young G. Subtype analysis of commission errors on the continuous performance test in children. Dev Neuropsychol 1991, 7:207-217.
35. Hock C., Villringer K., Muller-Spahn F., Wenzel R., Heekeren H., Schuh-Hofer S. Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS) - correlation with simultaneous rCBF-PET measurements. Brain Res 1997, 755:293-303.
36. Toronov V., Webb A., Choi J.H., Wolf M., Michalos A., Gratton E., et al. Investigation of human brain hemodynamics by simultaneous near-infrared spectroscopy and functional magnetic resonance imaging. Med Phys 2001, 28:521-527.
37. Jasper H.H. The ten-twenty electrode system of the international federation. Electroencephalogr Clin Neurophysiol 1958, 10:371-375.
38. Okamoto M., Dan H., Sakamoto K., Takeo K., Shimizu K., Kohno S., et al. Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10-20 system oriented for transcranial functional brain mapping. Neuroimage 2004, 21:99-111.
39. Zhao H., Tanikawa Y., Gao F., Onodera Y., Sassaroli A., Tanaka K., et al. Maps of optical differential pathlength factor of human adult forehead, somatosensory motor and occipital regions at multi-wavelengths in NIR. Phys Med Biol 2002, 47:2075-2093.
40. Ballard J.C. Assessing attention: comparison of response-inhibition and traditional continuous performance tests. J Clin Exp Neuropsychol 2001, 23:331-350.
41. Fallgatter A.J., Strik W.K. Reduced frontal functional asymmetry in schizophrenia during a cued continuous performance test assessed with near-infrared spectroscopy. Schizophr Bull 2000, 26:913-919.
42. Rubia K., Smith A.B., Halari R., Matsukura F., Mohammad M., Taylor E., et al. Disorder-specific dissociation of orbitofrontal dysfunction in boys with pure conduct disorder during reward and ventrolateral prefrontal dysfunction in boys with pure ADHD during sustained attention. Am J Psychiatry 2009, 166:83-94.
43. Chee P., Logan G., Schachar R., Lindsay P., Wachsmuth R. Effects of event rate and display time on sustained attention in hyperactive, normal, and control children. J Abnorm Child Psychol 1989, 17:371-391.
44. Fallgatter A.J., Strik W.K. Right frontal activation during the continuous performance test assessed with near-infrared spectroscopy in healthy subjects. Neurosci Lett 1997, 223:89-92.
45. Boecker M., Buecheler M.M., Schroeter M.L., Gauggel S. Prefrontal brain activation during stop-signal response inhibition: an event-related functional near-infrared spectroscopy study. Behav Brain Res 2007, 176:259-266.
46. Herrmann M.J., Plichta M.M., Ehlis A.C., Fallgatter A.J. Optical topography during a Go-NoGo task assessed with multi-channel near-infrared spectroscopy. Behav Brain Res 2005, 160:135-140.
47. Schroeter M.L., Zysset S., Kruggel F., Von Cramon D.Y. Age dependency of the hemodynamic response as measured by functional near-infrared spectroscopy. Neuroimage 2003, 19:555-564.
48. Takahashi M., Ikegami M. Differential frontal activation during exogenous and endogenous orientation of visuospatial attention: a near-infrared spectroscopy study. Neuropsychobiology 2008, 58:55-64.
49. Cubillo A., Halari R., Smith A., Taylor E., Rubia K. A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 2012, 48:194-215.
50. Christakou A., Murphy C.M., Chantiluke K., Cubillo A.I., Smith A.B., Giampietro V., et al. Disorder-specific functional abnormalities during sustained attention in youth with attention deficit hyperactivity disorder (AD/HD) and with autism. Mol Psychiatry 2013, 18:236-244.
51. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc Natl Acad Sci USA 2001, 98:676-682.
52. Liddle E.B., Hollis C., Batty M.J., Groom M.J., Totman J.J., Liotti M., et al. Task-related default mode network modulation and inhibitory control in AD/HD: effects of motivation and methylphenidate. J Child Psychol Psychiatry 2011, 52:761-771.
53. Cubillo A., Smith A.B., Barrett N., Giampietro V., Brammer M., Simmons A., et al. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory. Psychol Med 2013, 19:1-14.
54. Gamo N.J., Wang M., Arnsten A.F. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry 2010, 49:1011-1023.
55. Tucker D.M., Williamson P.A. Asymmetric neural control systems in human self-regulation. Psychol Rev 1984, 91:185-215.
56. Cubillo A., Smith A.B., Barrett N., Giampietro V., Brammer M.J., Simmons A., et al. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive AD/HD boys. Cereb Cortex 2014, 24:174-185.
57. Kono T., Matsuo K., Tsunashima K., Kasai K., Takizawa R., Rogers M.A., et al. Multiple-time replicability of near-infrared spectroscopy recording during prefrontal activation task in healthy men. Neurosci Res 2007, 57:504-512.
58. Schecklmann M., Ehlis A.C., Plichta M.M., Fallgatter A.J. Functional near-infrared spectroscopy: a long-term reliable tool for measuring brain activity during verbal fluency. Neuroimage 2008, 43:147-155.